Characteristics of pronostic groups according to EuroFlow immunophenotype. (TIFF 1364 kb

Alba L. Combita

Alba M. Campos

Jovanny Zabaleta

Julio Solano

Lauren F. Raney

Leonardo J. Enciso

Maria V. Herrera

Nataly Cruz-Rodriguez

Niyireth Peñaloza

Olga C. Lozano

Paula L. Pinzon

Sandra Quijano

Journal of Experimental & Clinical Cancer Research

Nataly Cruz-Rodriguez (3474320)

Alba Combita (3474341)

Leonardo Enciso (3474326)

Lauren Raney (3802960)

Paula Pinzon (3474350)

Olga Lozano (3474332)

Alba Campos (3802954)

Niyireth Peñaloza (3802975)

Julio Solano (3474347)

Maria Herrera (3474338)

Jovanny Zabaleta (631135)

Sandra Quijano (3474329)

The Francis Crick Institute

Additional file 2: of Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL

Expression levels of immunophenotypic markers in the two groups formed at the extremes of heatmap (group 1 and group 3) with different clinical characteristics. No statistically significant differences were observed in the expression of CD20, CD58, CD66, CD117, CD34, CD33, SmIgM, CD13, Lambda, CD9, TdT, CD22, CD24, SSC. (TIFF 1519 kb

Additional file 3: of Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL

Springer - Publisher Connector

Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL

Comparative analysis of mean fluorescence channels for the 19 markers included in the Euroflow panel and the parameters of light scattering (SSC and FSC) of leukemic cells from 42 B-ALL adult patients compared to three normal bone marrow samples. The box incorporates the middle quartiles; the line represents the median value: the whiskers indicate the minimum and maximum values. There is gain in expression of CD45, CD10, CD58, CD22, CD66, CD24, CD34, CD19 and FSC, SSC in B-ALL samples (B-ALL) as compared to normal bone marrow (Normal). There is loss in expression of CD38, CD117, CD9, TdT in B-ALL samples as compared to normal bone marrow. * P <0.05 with respect of pre-pre-B normal cells. (TIFF 910 kb

Additional file 1: of Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL

file:///data/core-remote/dit/data/Springer-OA/pdf/4b5/aHR0cDovL2xpbmsuc3ByaW5nZXIuY29tLzEwLjExODYvczEzMDQ2LTAxNy0wNTA2LTQucGRm.pdf

Prognostic stratification improvement by integrating ID1/ID3/IGJ gene expression signature and immunophenotypic profile in adult patients with B-ALL

Abstract

Similar works

Full text

Available Versions

The Francis Crick Institute

The Francis Crick Institute

Springer - Publisher Connector

The Francis Crick Institute